Predictors and Impact of Thirty-Day Readmission on Patient Outcomes and Health Care Costs after Reduced-Toxicity Conditioning Allogeneic Hematopoietic Cell Transplantation

Thirty-day readmission (30-DR) has become an important quality-of-care measure. Allogeneic hematopoietic cell transplantation (allo-HCT) presents a medical setting with higher readmission rates. We analyzed factors affecting 30-DR and its impact on patient outcomes and on health care costs in 91 pat...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Biol Blood Marrow Transplant
Autori principali: Rauenzahn, Sherri, Truong, Quoc, Cumpston, Aaron, Goff, Londia, Leadmon, Sonia, Evans, Kim, Zhang, Jianjun, Wen, Sijin, Craig, Michael, Hamadani, Mehdi, Kanate, Abraham S.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2013
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4557764/
https://ncbi.nlm.nih.gov/pubmed/24361913
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2013.12.559
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi